Tuesday, November 26, 2013 8:42:03 PM
First, let's talk about an actual travesty, one that is disgusting and unethical. This travesty involves a CEO named Lisenby who released BS in multiple PRs during the past four years (e.g., PR from 10/4/10, timelines in March 2013 PRs) that had investors spending their hard earned money under false pretenses. The BS started with the Bioharp scam and continued on with the land scam. In addition to this travesty, Lisenby has zippo substantive accomplishments for investors during at least the past four years (which is pathetic).
After the garbage that Lisenby has inflicted on investors during the past four years, I don't think that investors need to worry at all about Lisenby's feelings. He has treated investors like garbage during the past four years and he can be given the same treatment by investors.
As for not communicating, Lisenby can hide under a rock for the next 20 years if he wishes. The aforementioned BS and scams will continue to be discussed for a long, long time. Finally, there is zero evidence that Lisenby is working behind the scenes or anywhere else for shareholders so that notion can be easily dismissed.
imo
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM